Moderna: 'Short Term Delays' In Production Delays Release Of Vaccine Doses

CAMBRIDGE, Mass. (WBZ NewsRadio) — Moderna said Tuesday that “short term delays” in production at its New Jersey contractor Catalenta has caused delays in the release of some COVID-19 vaccine doses.

Moderna said “these delays are expected to be resolved in the near term and are not expected to impact monthly delivery targets.”

Read More: Clark Pushes For Centralized Vaccine Pre-Registration System In Mass.

The bio-tech company went on to say they expect the first 100 million doses of the vaccine will be delivered by the end of the first quarter 2021. So far, 45.4 million doses have been supplied to the U.S. government.

In a press release, Moderna said the “Company has moved forward delivery of its second 100 million doses by one month, from end of June 2021 to end of May 2021. It has moved forward delivery of its third 100 million doses by two months, from end of September 2021 to end of July 2021.”

Follow WBZ NewsRadio: Facebook | Twitter | Instagram | iHeartmedia App

(Photo: Getty Images)

Sponsored Content

Sponsored Content